Silico analysis of the target and possible mechanism of lomustine in the treatment of primary glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silico analysis of the target and possible mechanism of lomustine in the treatment of primary glioblastoma

Published:2022-12-08 Issue:1 Volume:29 Page:
ISSN:1610-2940
Container-title:Journal of Molecular Modeling
language:en
Short-container-title:J Mol Model

Author:

Zhang Tieying,Zhang Dongdong,Shi Feng

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Computational Theory and Mathematics,Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Catalysis

Link

https://link.springer.com/content/pdf/10.1007/s00894-022-05405-3.pdf

Reference24 articles.

1. Lah TT, Novak M, Breznik B (2020) Brain malignancies: Glioblastoma and brain metastases. Semin Cancer Biol 60:262–273. https://doi.org/10.1016/j.semcancer.2019.10.010

2. Carlsson SK, Brothers SP, Wahlestedt C (2014) Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med 6(11):1359–1370. https://doi.org/10.15252/emmm.201302627

3. Wen PY, Packer RJ (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications. Neuro Oncol 23(8):1215–1217. https://doi.org/10.1093/neuonc/noab120

4. Jones J, Nguyen H, Drummond K, Morokoff A (2021) Circulating Biomarkers for Glioma: A Review. Neurosurgery 88(3):E221–E230. https://doi.org/10.1093/neurons/nyaa540

5. Kim S, Thiessen PA, Bolton EE et al (2016) PubChem Substance and Compound databases. Nucleic Acids Res 44(D1):D1202–D1213. https://doi.org/10.1093/nar/gkv951

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations;International Journal of Biological Macromolecules;2024-10

2. RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist;Frontiers in Oncology;2023-05-29

3. Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors;International Journal of Molecular Sciences;2023-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3